MX9702148A - Metodos para inhibir la mitosis endometrial. - Google Patents

Metodos para inhibir la mitosis endometrial.

Info

Publication number
MX9702148A
MX9702148A MX9702148A MX9702148A MX9702148A MX 9702148 A MX9702148 A MX 9702148A MX 9702148 A MX9702148 A MX 9702148A MX 9702148 A MX9702148 A MX 9702148A MX 9702148 A MX9702148 A MX 9702148A
Authority
MX
Mexico
Prior art keywords
methods
inhibiting endometrial
mitoses
endometrial mitoses
inhibiting
Prior art date
Application number
MX9702148A
Other languages
English (en)
Other versions
MXPA97002148A (es
Inventor
Susan Margaret Boss-Bader
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MXPA97002148A publication Critical patent/MXPA97002148A/es
Publication of MX9702148A publication Critical patent/MX9702148A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Se describe un método para inhibir la mitosis endometrial que comprende administrar a un humano en necesidad del mismo una cantidad efectiva de un compuesto que tiene formula (I) en la que R1 y R3 son independientemente hidrogeno, -CH3 (a) o (b), en el que Ar es fenilo opcionalmente sustituido; R2 se selecciona del grupo que consiste de pirrolidina, hexametilenimino y piperidino; y una sal o solvato farmacéuticamente aceptable del mismo.
MX9702148A 1994-09-22 1995-09-20 Metodos para inhibir la mitosis endometrial. MX9702148A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08310292 1994-09-22
US08/310,292 US5843964A (en) 1994-09-22 1994-09-22 Methods of inhibiting endometrial mitoses
PCT/US1995/011926 WO1996009050A1 (en) 1994-09-22 1995-09-20 Methods of inhibiting endometrial mitoses

Publications (2)

Publication Number Publication Date
MXPA97002148A MXPA97002148A (es) 1997-06-01
MX9702148A true MX9702148A (es) 1997-06-28

Family

ID=23201835

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9702148A MX9702148A (es) 1994-09-22 1995-09-20 Metodos para inhibir la mitosis endometrial.

Country Status (16)

Country Link
US (1) US5843964A (es)
EP (1) EP0782446A4 (es)
JP (1) JPH10506108A (es)
KR (1) KR970706000A (es)
CN (1) CN1158086A (es)
AU (1) AU692309B2 (es)
CA (1) CA2200451A1 (es)
CZ (1) CZ83997A3 (es)
FI (1) FI971197A0 (es)
HU (1) HUT76828A (es)
IL (1) IL115383A0 (es)
MX (1) MX9702148A (es)
NO (1) NO971029D0 (es)
NZ (1) NZ294123A (es)
WO (1) WO1996009050A1 (es)
ZA (1) ZA957949B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2161964C2 (ru) * 1994-08-22 2001-01-20 Эли Лилли Энд Компани Способ ингибирования (угнетения) эндометриального рака
DK1175433T3 (da) 1999-05-04 2005-09-19 Strakan Int Ltd Androgenglycosider og androgen aktivitet deraf
JP6010119B2 (ja) 2011-06-30 2016-10-19 ヘラマンタイトン コーポレイション 結束バンド緊張および裁断ツール
USD692738S1 (en) 2011-06-30 2013-11-05 Hellermanntyton Corporation Cable tie tensioning and cut-off tool
WO2016094855A1 (en) 2014-12-12 2016-06-16 Hellermanntyton Corporation Compound tension and calibration mechanism for cable tie tensioning and cut-off tool

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5461065A (en) * 1993-10-15 1995-10-24 Eli Lilly And Company Methods for inhibiting endometriosis
ZA956988B (en) * 1994-08-22 1997-02-21 Lilly Co Eli Methods of inhibiting primary endometrial hyperplasia.

Also Published As

Publication number Publication date
EP0782446A4 (en) 1999-01-07
ZA957949B (en) 1997-03-20
FI971197A (fi) 1997-03-21
NZ294123A (en) 1999-09-29
IL115383A0 (en) 1995-12-31
HUT76828A (en) 1997-11-28
AU3678895A (en) 1996-04-09
JPH10506108A (ja) 1998-06-16
CA2200451A1 (en) 1996-03-28
NO971029L (no) 1997-03-06
US5843964A (en) 1998-12-01
AU692309B2 (en) 1998-06-04
KR970706000A (ko) 1997-11-03
CZ83997A3 (en) 1997-07-16
FI971197A0 (fi) 1997-03-21
EP0782446A1 (en) 1997-07-09
WO1996009050A1 (en) 1996-03-28
CN1158086A (zh) 1997-08-27
NO971029D0 (no) 1997-03-06

Similar Documents

Publication Publication Date Title
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
AU7578794A (en) Methods for inhibiting endometriosis
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
MX9701334A (es) Metodos para inhibir la degeneracion de protesis oseas.
MX9709466A (es) Medicamento para inhibir el melanoma.
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
MX9702148A (es) Metodos para inhibir la mitosis endometrial.
MX9701333A (es) Metodos para inhibir el daño neuronal.
MX9701327A (es) Metodos para inhibir el cancer endometrial.
MY113406A (en) Methods of inhibiting physiological conditions associated with an excess of bradykinin
MX9701332A (es) Metodos para curar y reparar fracturas oseas.
MX9701359A (es) Metodos para la inhibicion de la hiperplasia endometrial primaria.
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
MX9701328A (es) Metodos de reduccion de la cicatrizacion en la curacion de heridas.
MX9705940A (es) Metodos y composiciones para inhibir los efectos de la interleucina 6.
MX9705215A (es) Uso de 2-fenil-3-aroilbenzotiofenos para inhibir los efectos de la hormona del crecimiento.
MX9706072A (es) Metodos de inhibicion de la adhesion celula-celula.
MX9705697A (es) Metodos para reducir los niveles de calcio del suero.
MX9702853A (es) Metodos para inhibir condiciones asociadas con el neuropeptido "y".
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.
MX9709651A (es) Metodos para modulacion del factor de transcripcion nf-kb.
MX9706520A (es) Metodos para inhibir el cancer de ovario.
MX9806036A (es) Compuestos para inhibir tumores en el colon.